Your browser doesn't support javascript.
loading
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Pearson, Andrew D J; de Rojas, Teresa; Karres, Dominik; Reaman, Gregory; Scobie, Nicole; Fox, Elizabeth; Lesa, Giovanni; Ligas, Franca; Norga, Koen; Nysom, Karsten; Pappo, Alberto; Weigel, Brenda; Weiner, Susan; Vassal, Gilles.
Afiliação
  • Pearson ADJ; ACCELERATE, 1200 Brussels, Belgium. Electronic address: andy1pearson@btinternet.com.
  • de Rojas T; ACCELERATE, 1200 Brussels, Belgium.
  • Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency, Amsterdam, Netherlands.
  • Reaman G; US Food and Drug Administration, Silver Spring, MD, USA.
  • Scobie N; Zoe4Life, Sullens, Switzerland.
  • Fox E; St Jude Children's Research Hospital, Memphis, TN, USA.
  • Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency, Amsterdam, Netherlands.
  • Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency, Amsterdam, Netherlands.
  • Norga K; Antwerp University Hospital, Antwerp, Belgium; Paediatric Committee of the European Medicines Agency, Amsterdam, Netherlands; Federal Agency for Medicines and Health Products, Brussels, Belgium.
  • Nysom K; Righospitalet, Copenhagen, Denmark.
  • Pappo A; St Jude Children's Research Hospital, Memphis, TN, USA.
  • Weigel B; University of Minnesota, MN, USA.
  • Weiner S; Children's Cancer Cause, Washington, DC, USA.
  • Vassal G; ACCELERATE, 1200 Brussels, Belgium; Gustave Roussy Cancer Centre, Paris, France.
Lancet Oncol ; 23(11): 1354-1357, 2022 11.
Article em En | MEDLINE | ID: mdl-36328007

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenvolvimento de Medicamentos / Oncologia Limite: Child / Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenvolvimento de Medicamentos / Oncologia Limite: Child / Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article